Please login to the form below

Not currently logged in
Email:
Password:

Oxford Pharmascience adds to board

John Goddard is former head of group strategic planning and business at AstraZeneca
John Goddard Oxford Pharmascience

Oxford Pharmascience has bulked up its board with the appointment of industry veteran John Goddard as independent non-executive director.

Goddard has years of experience in pharma including a spell as head of group strategic planning and business development at AstraZeneca until his retirement in 2010.

He joined AZ after his former company Zeneca merged with Astra in 1999.

Oxford Pharmascience's chair Dave Norwood commented that Goddard's experience in the industry would be valuable as the company initiates the commercialisation of its drug pipeline.

10th March 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics